Raymond R. Tjandrawinata

Department of Business Development and Dexa Laboratories of Biomolecular Sciences, PT Dexa Medica

Executive Director

Tangerang

Indonesia

SCHOLARLY PAPERS

5

DOWNLOADS
Rank 19,888

SSRN RANKINGS

Top 19,888

in Total Papers Downloads

2,391

SSRN CITATIONS

0

CROSSREF CITATIONS

3

Scholarly Papers (5)

1.

The Impact of Mergers and Acquisitions in Research-Based Pharmaceutical Companies on Productivity

Number of pages: 20 Posted: 09 Jan 2012
Raymond R. Tjandrawinata and Destrina Grace Simanjuntak
Department of Business Development and Dexa Laboratories of Biomolecular Sciences, PT Dexa Medica and Dexa Laboratories of Biomolecular Sciences, Dexa Medica Group
Downloads 1,051 (20,052)
Citation 1

Abstract:

Loading...

mergers and acquisitions (M&A), R&D expenditure, sales revenue, R&D Intensity, total approval, new molecular entity

2.

Impact of Profitability, R&D Intensity, and Cash Flow on R&D Expenditure in Pharmaceutical Companies

Number of pages: 13 Posted: 05 May 2011
Destrina Grace Simanjuntak and Raymond R. Tjandrawinata
Dexa Laboratories of Biomolecular Sciences, Dexa Medica Group and Department of Business Development and Dexa Laboratories of Biomolecular Sciences, PT Dexa Medica
Downloads 548 (49,291)
Citation 4

Abstract:

Loading...

Research and Development Expenditure, Profitability, R&D Intensity, Cash Flow

3.

Factors Influencing Sales Revenue in the Multinational Pharmaceutical Companies

Number of pages: 13 Posted: 28 Jul 2011
Destrina Grace Simanjuntak and Raymond R. Tjandrawinata
Dexa Laboratories of Biomolecular Sciences, Dexa Medica Group and Department of Business Development and Dexa Laboratories of Biomolecular Sciences, PT Dexa Medica
Downloads 424 (67,792)

Abstract:

Loading...

sales revenue, profitability, R&D expenditure, marketing expenditure

4.

M&A of Generic Pharmaceutical Companies Increases Productivity

Number of pages: 13 Posted: 20 Oct 2011
Destrina Grace Simanjuntak and Raymond R. Tjandrawinata
Dexa Laboratories of Biomolecular Sciences, Dexa Medica Group and Department of Business Development and Dexa Laboratories of Biomolecular Sciences, PT Dexa Medica
Downloads 188 (160,617)

Abstract:

Loading...

M&A, R&D expenditure, profitability, R&D intensity, total approval, generic drug

5.

Sales Revenue Determinants for Generic Pharmaceutical Companies

Number of pages: 11 Posted: 26 Sep 2011
Destrina Grace Simanjuntak and Raymond R. Tjandrawinata
Dexa Laboratories of Biomolecular Sciences, Dexa Medica Group and Department of Business Development and Dexa Laboratories of Biomolecular Sciences, PT Dexa Medica
Downloads 180 (167,068)

Abstract:

Loading...

profitability, sales revenue, market share, new generic product, pharmaceutical generic companies